Sunovion advances schizophrenia drug for bipolar disorder
Sunovion Pharmaceuticals Inc. said the U.S. Food and Drug Administration has accepted its applications to expand the indication of its schizophrenia drug, Latuda, to be used as a treatment for bipolar disorder.
Join the discussion below, or Read more at Business Journal.
#1 Nov 3, 2012
Latuda should only be administered to patients receiving in-patient care if my experience is anything to go on! That is one wicked medicine! Expect all of the side effects at once. It was horrible for me.
Add your comments below
|Looking for Identical Twins of Schizophrenics ... (Nov '11)||Aug '17||Allynn25||32|
|Son still having symptoms (Feb '17)||Aug '17||Dawn001||3|
|Schizophrenia is eight different diseases, not one (Sep '14)||May '17||HumanSpirit||19|
|Im schizophrenic and bipolar and divorced with... (Dec '16)||Mar '17||Human||3|
|I have been cured from schizophrenia (Apr '09)||Feb '17||Joy||127|
|Ontario children and youth with ADHD often pres... (Jan '17)||Feb '17||Humanspirit||3|
|Study: Smoking May Help Treat Schizophrenia (Jan '17)||Feb '17||Philadelphia is t...||5|
Find what you want!
Search Schizophrenia Forum Now
Copyright © 2017 Topix LLC